Multiple sclerosis: monitoring long-term treatments in multiple sclerosis

Abstract

Patients with relapsing-remitting multiple sclerosis have been shown to benefit from disease-modifying treatments over prolonged periods. More focus should now be placed on monitoring the long-term evolution of this disease (making use of tools such as MRI), alongside the patients' response and adherence to such treatments.